| Literature DB >> 27181590 |
Leandro Ceotto Freitas Lima1,2, Soraya Wilke Saliba2, João Marcus Oliveira Andrade3, Maria Luisa Cunha2, Puebla Cassini-Vieira2, John David Feltenberger4, Lucíola Silva Barcelos2, André Luiz Sena Guimarães3, Alfredo Mauricio Batista de-Paula3, Antônio Carlos Pinheiro de Oliveira2, Sérgio Henrique Sousa Santos5,6.
Abstract
Different factors may contribute to the development of neurodegenerative diseases. Among them, metabolic syndrome (MS), which has reached epidemic proportions, has emerged as a potential element that may be involved in neurodegeneration. Furthermore, studies have shown the importance of the sirtuin family in neuronal survival and MS, which opens the possibility of new pharmacological targets. This study investigates the influence of sirtuin metabolic pathways by examining the functional capacities of glucose-induced obesity in an excitotoxic state induced by a quinolinic acid (QA) animal model. Mice were divided into two groups that received different diets for 8 weeks: one group received a regular diet, and the other group received a high-fat diet (HF) to induce MS. The animals were submitted to a stereotaxic surgery and subdivided into four groups: Standard (ST), Standard-QA (ST-QA), HF and HF-QA. The QA groups were given a 250 nL quinolinic acid injection in the right striatum and PBS was injected in the other groups. Obese mice presented with a weight gain of 40 % more than the ST group beyond acquiring an insulin resistance. QA induced motor impairment and neurodegeneration in both ST-QA and HF-QA, although no difference was observed between these groups. The HF-QA group showed a reduction in adiposity when compared with the groups that received PBS. Therefore, the HF-QA group demonstrated a commitment-dependent metabolic pathway. The results suggest that an obesogenic diet does not aggravate the neurodegeneration induced by QA. However, the excitotoxicity induced by QA promotes a sirtuin pathway impairment that contributes to metabolic changes.Entities:
Keywords: Huntington’s disease; Metabolic syndrome; Quinolinic acid; Sirtuin
Mesh:
Substances:
Year: 2016 PMID: 27181590 DOI: 10.1007/s12035-016-9927-x
Source DB: PubMed Journal: Mol Neurobiol ISSN: 0893-7648 Impact factor: 5.590